Structure-Activity Relationship Studies of 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine (FPMINT) Analogues as Inhibitors of Human Equilibrative Nucleoside Transporters.
Saved in:
| Title: | Structure-Activity Relationship Studies of 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine (FPMINT) Analogues as Inhibitors of Human Equilibrative Nucleoside Transporters. |
|---|---|
| Authors: | Li R; Department of Pharmacology and Pharmacy, University of Hong Kong, Pokfulam, Hong Kong SAR, China., Mak WW; Department of Pharmacology and Pharmacy, University of Hong Kong, Pokfulam, Hong Kong SAR, China., Li J; Department of Pharmacology and Pharmacy, University of Hong Kong, Pokfulam, Hong Kong SAR, China., Zheng C; Department of Pharmacology and Pharmacy, University of Hong Kong, Pokfulam, Hong Kong SAR, China., Shiu PH; Department of Pharmacology and Pharmacy, University of Hong Kong, Pokfulam, Hong Kong SAR, China., Seto SW; Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China., Lee SM; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, China., Leung GP; Department of Pharmacology and Pharmacy, University of Hong Kong, Pokfulam, Hong Kong SAR, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2022 Feb 21; Vol. 13, pp. 837555. Date of Electronic Publication: 2022 Feb 21 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2022.837555 |